Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Coumadin in Preventing Periprocedural Thrombo-Embolism as a Complication of Radio Frequency Catheter Ablation in High-risk Atrial Fibrillation Patients

NCT01006876 is registered in ClinicalTrials.gov with Texas Cardiac Arrhythmia Research Foundation as lead sponsor.

NCT NCT01006876
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01006876 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Coumadin in Preventing Periprocedural Thrombo-Embolism as a Complication of Radio Frequency Catheter Ablation in High-risk Atrial Fibrillation Patients
Lead sponsor
Texas Cardiac Arrhythmia Research Foundation
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2010
Completion date
April 30, 2014
Enrollment
1,584 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

thromboembolism